Although a large volume of anecdotal reports have been published over the last few years affirming the value of LSD microdosing, there has been very little scientific or empirical study on this ...

An incredible, first-of-its-kind trial testing the pain-killing properties of LSD microdoses has delivered the compelling suggestion that tiny, non-psychedelic doses of this infamous drug could serve ...

I became a neuroscientist to help us understand how humans gain deeper insight and observation into themselves, life, and being during altered states of consciousness. I never expected to write a post ...

Australian R&D company MindBio Therapeutics conducted a first-ever Phase 2a take-home microdosing trial to treat depression.. 53% of patients went into complete depression remission after 8 weeks of ...

Better moods, higher concentration levels, more creativity - and all without the usual risks associated with hard drugs: Proponents of microdosing LSD - taking tiny fractions of the amount needed for ...

Neuro-pharmaceutical and psychedelics company Mind Medicine Inc. MNMD MMED MMQ announced Friday the initiation of Phase 2a proof-of-concept trial of LSD (lysergic acid diethylamide) in adult patients ...

LSD and psilocybin are known for their capacity to enhance the complexity or “diversity” of brain activity. But does THC work in the same way? A recent study spearheaded by Conor Murray at the ...

This article was originally published on The Conversation. Read the original article. It may seem like a doomed attempt to mix business and pleasure. But a growing number of young professionals in ...

MindBio Therapeutics Corp. said that “MB22001, a proprietary and self-titratable form of Lysergic Acid Diethylamide (LSD) designed for safe take home microdosing” has been approved for take-home use ...

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. When Ayelet Waldman greets me at the door of her two-story home in Berkeley, ...

After a several years of bubbling just beneath the surface, psychedelic drugs are having their latest moment of public acceptance. Meanwhile, groups as disparate as Silicon Valley executives and ...